FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751981258> ?p ?o ?g. }

• W2751981258 endingPage "53" @default.
• W2751981258 startingPage "46" @default.
• W2751981258 abstract "Glycerol phenylbutyrate (GPB) is approved in the US for the management of patients 2 months of age and older with urea cycle disorders (UCDs) that cannot be managed with protein restriction and/or amino acid supplementation alone. Limited data exist on the use of nitrogen conjugation agents in very young patients. Seventeen patients (15 previously on other nitrogen scavengers) with all types of UCDs aged 2 months to 2 years were switched to, or started, GPB. Retrospective data up to 12 months pre-switch and prospective data during initiation of therapy were used as baseline measures. The primary efficacy endpoint of the integrated analysis was the successful transition to GPB with controlled ammonia (< 100 μmol/L and no clinical symptoms). Secondary endpoints included glutamine and levels of other amino acids. Safety endpoints included adverse events, hyperammonemic crises (HACs), and growth and development. 82% and 53% of patients completed 3 and 6 months of therapy, respectively (mean 8.85 months, range 6 days–18.4 months). Patients transitioned to GPB maintained excellent control of ammonia and glutamine levels. There were 36 HACs in 11 patients before GPB and 11 in 7 patients while on GPB, with a reduction from 2.98 to 0.88 episodes per year. Adverse events occurring in at least 10% of patients while on GPB were neutropenia, vomiting, diarrhea, pyrexia, hypophagia, cough, nasal congestion, rhinorrhea, rash/papule. GPB was safe and effective in UCD patients aged 2 months to 2 years. GPB use was associated with good short- and long-term control of ammonia and glutamine levels, and the annualized frequency of hyperammonemic crises was lower during the study than before the study. There was no evidence for any previously unknown toxicity of GPB." @default.
• W2751981258 created "2017-09-15" @default.
• W2751981258 creator A5000261070 @default.
• W2751981258 creator A5002194433 @default.
• W2751981258 creator A5011564602 @default.
• W2751981258 creator A5021956757 @default.
• W2751981258 creator A5027630774 @default.
• W2751981258 creator A5032043915 @default.
• W2751981258 creator A5032217427 @default.
• W2751981258 creator A5036178187 @default.
• W2751981258 creator A5050648441 @default.
• W2751981258 creator A5057001105 @default.
• W2751981258 creator A5077361345 @default.
• W2751981258 date "2017-11-01" @default.
• W2751981258 modified "2023-10-18" @default.
• W2751981258 title "Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years" @default.
• W2751981258 cites W1755105077 @default.
• W2751981258 cites W1965443388 @default.
• W2751981258 cites W1966191179 @default.
• W2751981258 cites W1990178743 @default.
• W2751981258 cites W1993880563 @default.
• W2751981258 cites W1996979685 @default.
• W2751981258 cites W2020846928 @default.
• W2751981258 cites W2038984648 @default.
• W2751981258 cites W2041404258 @default.
• W2751981258 cites W2049064875 @default.
• W2751981258 cites W2052731430 @default.
• W2751981258 cites W2097097560 @default.
• W2751981258 cites W2128596992 @default.
• W2751981258 cites W2132062202 @default.
• W2751981258 cites W2170491580 @default.
• W2751981258 cites W2171923558 @default.
• W2751981258 cites W2271042168 @default.
• W2751981258 cites W2496766869 @default.
• W2751981258 doi "https://doi.org/10.1016/j.ymgme.2017.09.002" @default.
• W2751981258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28916119" @default.
• W2751981258 hasPublicationYear "2017" @default.
• W2751981258 type Work @default.
• W2751981258 sameAs 2751981258 @default.
• W2751981258 citedByCount "15" @default.
• W2751981258 countsByYear W27519812582017 @default.
• W2751981258 countsByYear W27519812582018 @default.
• W2751981258 countsByYear W27519812582019 @default.
• W2751981258 countsByYear W27519812582020 @default.
• W2751981258 countsByYear W27519812582021 @default.
• W2751981258 countsByYear W27519812582022 @default.
• W2751981258 countsByYear W27519812582023 @default.
• W2751981258 crossrefType "journal-article" @default.
• W2751981258 hasAuthorship W2751981258A5000261070 @default.
• W2751981258 hasAuthorship W2751981258A5002194433 @default.
• W2751981258 hasAuthorship W2751981258A5011564602 @default.
• W2751981258 hasAuthorship W2751981258A5021956757 @default.
• W2751981258 hasAuthorship W2751981258A5027630774 @default.
• W2751981258 hasAuthorship W2751981258A5032043915 @default.
• W2751981258 hasAuthorship W2751981258A5032217427 @default.
• W2751981258 hasAuthorship W2751981258A5036178187 @default.
• W2751981258 hasAuthorship W2751981258A5050648441 @default.
• W2751981258 hasAuthorship W2751981258A5057001105 @default.
• W2751981258 hasAuthorship W2751981258A5077361345 @default.
• W2751981258 hasBestOaLocation W27519812581 @default.
• W2751981258 hasConcept C126322002 @default.
• W2751981258 hasConcept C141071460 @default.
• W2751981258 hasConcept C185592680 @default.
• W2751981258 hasConcept C197934379 @default.
• W2751981258 hasConcept C203092338 @default.
• W2751981258 hasConcept C2776694085 @default.
• W2751981258 hasConcept C2777063308 @default.
• W2751981258 hasConcept C2777468819 @default.
• W2751981258 hasConcept C2778570526 @default.
• W2751981258 hasConcept C2780852908 @default.
• W2751981258 hasConcept C2909310144 @default.
• W2751981258 hasConcept C515207424 @default.
• W2751981258 hasConcept C535046627 @default.
• W2751981258 hasConcept C55493867 @default.
• W2751981258 hasConcept C71924100 @default.
• W2751981258 hasConcept C77061444 @default.
• W2751981258 hasConcept C90924648 @default.
• W2751981258 hasConceptScore W2751981258C126322002 @default.
• W2751981258 hasConceptScore W2751981258C141071460 @default.
• W2751981258 hasConceptScore W2751981258C185592680 @default.
• W2751981258 hasConceptScore W2751981258C197934379 @default.
• W2751981258 hasConceptScore W2751981258C203092338 @default.
• W2751981258 hasConceptScore W2751981258C2776694085 @default.
• W2751981258 hasConceptScore W2751981258C2777063308 @default.
• W2751981258 hasConceptScore W2751981258C2777468819 @default.
• W2751981258 hasConceptScore W2751981258C2778570526 @default.
• W2751981258 hasConceptScore W2751981258C2780852908 @default.
• W2751981258 hasConceptScore W2751981258C2909310144 @default.
• W2751981258 hasConceptScore W2751981258C515207424 @default.
• W2751981258 hasConceptScore W2751981258C535046627 @default.
• W2751981258 hasConceptScore W2751981258C55493867 @default.
• W2751981258 hasConceptScore W2751981258C71924100 @default.
• W2751981258 hasConceptScore W2751981258C77061444 @default.
• W2751981258 hasConceptScore W2751981258C90924648 @default.
• W2751981258 hasFunder F4320309233 @default.
• W2751981258 hasFunder F4320332161 @default.
• W2751981258 hasFunder F4320332578 @default.
• W2751981258 hasFunder F4320337472 @default.

• next